Exposure to vitamin K antagonists during pregnancy.
Schaefer
Christof
C
The Research Institute for Risk and Safety, Information of Medicines in Pregnancy and Lactation, Berlin, Germany.
D002986:Clinical Trials as Topic; D015331:Cohort Studies; D005260:Female; D006801:Humans; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D013723:Teratogens; D013927:Thrombosis / Q000188:drug therapy; D014812:Vitamin K / Q000037:antagonists & inhibitors*
D013723:Teratogens; D014812:Vitamin K